... Betterchem Health Drug Information DMFs Portal 21CFR Search Site Map Our server located the best source for detailed information. We also recommend that you use our engine focused on research literature. [About My Drug Index] Relevant keywords with links to related About My Drug pages and our medical encyclopedia (Encyc )&# 133 orlistat, -li-stat, is used as an aid to help you lose weight, the medicine prevents the digestion, the fat you eat, fats that are not digested cannot be absorbed and therefore do not contribute calories, to give the greatest weight loss, orlistat, used with a weight-reduction diet, orlistat, dosage forms, oral, capsules, for orlistat, allergic reaction to orlistat, allergic to any other substances, foods, preservatives, dyes, orlistat has not been studied in pregnant women, orlistat may decrease the amount, certain vitamins, body can absorb from the food you eat, make sure you have discussed with a physician the use, this medication during pregnancy, when breast-feeding (Encyc ), not known whether orlistat passes into breast milk, ...

... Betterchem Health Drug Information DMFs Portal 21CFR Search Site Map Our server located the best source for detailed information. We also recommend that you use our engine focused on research literature. [About My Drug Index] Relevant keywords with links to related About My Drug pages and our medical encyclopedia (Encyc )&# 133 ' li stat, orlistat is used with a low-calorie diet to help you lose weight, maintain my weight after weight loss, orlistat is used in patients with a certain weight who may also have high blood pressure (Encyc ), diabetes, high cholesterol, heart disease (Encyc ), orlistat is a prescription drug, lipase inhibitors, in my intestines, where it blocks some, the fat you eat from being absorbed and disgested, this undigested fat is then removed, in my bowel movements, bm, orlistat comes as a capsule, take by mouth, usually taken three times a day with each main meal that contains fat, each time you take orlistat, meal should contain no more than about 30 %, calories from fat, take orlistat during, ...

... sites that now dominate Bing, Google, and Yahoo. Near the top of our pages, you will find a link to content that best matches your query. Click the Chemical Profile link above for detailed information. Visit Betterchem's Drug Index for Exclusivity Patents and market exclusivity Drug Information Prescribing and other information DMFs Type 2 drug master files Databases Free access to database search 21 CFR FDA regulations for this drug Federal Register FR search results for this drug Drug Recalls For Rx's using this API FDA Approval Activities for this Drug Xenical / Orlistat Capsules, 120 mg [patient instructions] Roche NDA 20-766 4 / 26 / 99 4 / 27 / 99 4 / 27 / 99 8 / 13 / 99 Xenical / Orlistat Capsules, 120 mg Roche NDA 20766 / S7 6 / 25 / 01 6 / 25 / 01 Indication: XENICAL (orlistat) is a lipase inhibitor for obesity management that acts by inhibiting the absorption of dietary fats. Xenical (Orlistat) Capsules, Hoffman-La Roche, Inc, Labeling Revision | Xenical (Orlistat) Capsules, Hoffman-LaRoche, ...

... Betterchem Health Drug Information DMFs Portal 21CFR Search Site Map FDA News Archive [index page] February 12, 2007_Rx Weight-Loss Drug Orlistat Approved for OTC Sales FDA has approved orlistat as an over-the-counter (OTC) weight-loss aid for overweight adults. FDA first approved the drug in 1999 as a prescription treatment for obesity. Orlistat still will be dispensed by prescription for obesity at a higher dose than the OTC version, which will be sold under the name Alli. Orlistat helps produce weight loss by decreasing the intestinal absorption of fat. http :// www.fda.gov / bbs / topics / NEWS / 2007 / NEW01557.html Two Approved Uses to be Removed from Antibiotic Ketek After considering the risks and benefits of the three approved uses of the antibiotic Ketek (telithromycin ), FDA has determined that two of those uses no longer support approval of the drug for those purposes. The two uses that will be dropped from the drug's labeling are acute bacterial sinusitis and acute bacterial exacerbations of chronic bronchitis. However, Ketek will stay on the market for treatment of mild-to-moderate community-acquired pneumonia.-Press ...

... Systemic) Orciprenaline Bronchodilators, Adrenergic (Oral / Injection) Bronchodilators, Adrenergic (Inhalation) Oretic Hydrochlorothiazide Diuretics, Thiazide (Systemic) Oreticyl Rauwolfia Alkaloids and Thiazide Diuretics (Systemic) Oreticyl Forte Rauwolfia Alkaloids and Thiazide Diuretics (Systemic) ORETON Methyl Androgens (Systemic) Orfadin Nitisinone (Systemic) Orfro Orphenadrine (Systemic) Organidin NR Guaifenesin (Systemic) Orgaran Danaparoid (Systemic) Orimune Poliovirus Vaccine Live Oral (Systemic) Poliovirus Vaccine (Systemic) Orinase Tolbutamide Antidiabetic Agents, Sulfonylurea (Systemic) ORLAAM Levomethadyl Levomethadyl (Systemic) Orlistat Details Orlistat (Oral — Local) Details Ornade Chlorpheniramine and Phenylpropanolamine Ornex Maximum Strength Caplets Decongestants and Analgesics (Systemic) Ornex Severe Cold No Drowsiness Caplets Cough / Cold Combinations (Systemic) Ornidyl Eflornithine (Systemic) Oro-Clense Chlorhexidine (Dental) Orphenadrine Details Orphenadrine (Systemic) Details Orphenadrine and Aspirin (Systemic) Details Orphenagesic Orphenadrine and Aspirin (Systemic) Orphenagesic Forte Orphenadrine and Aspirin (Systemic) Orphenate Orphenadrine (Systemic) ORS-bicarbonate Carbohydrates and Electrolytes (Systemic) ORS-citrate Carbohydrates and Electrolytes (Systemic) Back to Top If your drug is ...

... Betterchem Health Drug Information DMFs Portal 21CFR Search Site Map & nbsp [Index] | [A-Z] | [Continue] About My Drug X-Prep Liquid Laxatives (Oral) X-Seb Salicylic Acid (Topical) Xalatan Latanoprost Latanoprost (Ophthalmic) Xanax Alprazolam Benzodiazepines (Systemic) Xanax TS Benzodiazepines (Systemic) Xatral Alfuzosin (Systemic) Xeloda Capecitabine Capecitabine (Systemic) Xenical Orlistat Orlistat (Oral — Local) Xenon Xe 127 Radiopharmaceuticals (Diagnostic) Xenon Xe 133 Radiopharmaceuticals (Diagnostic) Xerac BP 5 Benzoyl Peroxide (Topical) Xifaxan Rifaximin (Oral-Local) Xigris Drotrecogin Alfa (Systemic) Xolair Omalizumab Injection Omalizumab (Systemic) Xopenex Levalbuterol Oral Inhalation Levalbuterol (Inhalation-Local) XSeb Pyrithione (Topical) XSeb Plus Pyrithione (Topical) Xylocaine Anesthetics (Topical) Anesthetics (Parenteral-Local) Anesthetics (Dental) Xylocaine 5 %Spinal Anesthetics (Parenteral-Local) Xylocaine Test Dose Anesthetics (Parenteral-Local) Xylocaine Viscous Lidocaine Viscous Anesthetics (Dental) Xylocaine-MPF Anesthetics (Parenteral-Local) Xylocaine-MPF with Glucose Anesthetics (Parenteral-Local) Xylometazoline (Nasal) Details Xyrem Sodium Oxybate (Systemic) Back to Top If your drug ...

... www.fda.gov / bbs / topics / news / 2006 / NEW01298.html_UPCOMING PUBLIC MEETINGS Jan. 20-Regulatory Process for Pediatric Mechanical Circulatory Support Devices (Ventricular Assist Devices) Under discussion: regulation and approval of circulatory support devices used for temporary support in pediatric patients Location: Rockville, Md. http :// www.fda.gov / OHRMS / DOCKETS / 98fr / 05-24271.htm Jan. 23-Joint meeting of the Nonprescription Drugs Advisory Committee and the Endocrinologic and Metabolic Drugs Advisory Committee Under discussion: pending application for over-the-counter use of the prescription weight-loss drug Orlistat Location: Bethesda, Md. http :// www.fda.gov / oc / advisory / accalendar / 2006 / cder12541d012306.html Jan. 24-Joint meeting of the Nonprescription Drugs Advisory Committee and the Pulmonary-Allergy Drugs Advisory Committee Under discussion: the continuing need to designate over-the-counter epinephrine metered-dose inhalers as an essential use of ozone-depleting substances Location: Bethesda, Md. http :// www.fda.gov / oc / advisory / accalendar / 2006 / cder12541d012406.html Feb. 8-9-FDA Anti-Counterfeit Drug Initiative Public Workshop and Vendor Display Under discussion: adoption of radio-frequency identification in the U.S. medicine ...

... involving FDA-regulated products from the past 60 days, go to Betterchem news page. http :// www.fda.gov / opacom / 7alerts.html._UPCOMING PUBLIC MEETINGS Jan. 20-Regulatory Process for Pediatric Mechanical Circulatory Support Under discussion: regulation and approval of circulatory support devices used for temporary support in pediatric patients http :// www.fda.gov / OHRMS / DOCKETS / 98fr / 05-24271.htm Jan. 23-Joint meeting of the Nonprescription Drugs Advisory Committee and the Endocrinologic and Metabolic Drugs Advisory Committee Under discussion: pending application for over-the-counter use of the prescription weight-loss drug Orlistat Location: Bethesda, Md. http :// www.fda.gov / oc / advisory / accalendar / 2006 / cder12541d012306.html Jan. 24-Joint meeting of the Nonprescription Drugs Advisory Committee and the Pulmonary-Allergy Drugs Advisory Committee Under discussion: the continuing need to designate over-the-counter epinephrine metered-dose inhalers as an essential use of ozone-depleting substances Location: Bethesda, Md. http :// www.fda.gov / oc / advisory / accalendar / 2006 / cder12541d012406.html_QUESTION OF THE WEEK How do biological products (biologics) differ from conventional drugs? In contrast to most drugs that are chemically ...

... News for: Search our Medical Encyclopedia for: Please choose from listed actives OCTREOTIDE OCUFEN OFLOXACIN OLANZAPINE OLMESARTAN OLOPATADINE OLSALAZINE OMEPRAZOLE ONDANSETRON ORLISTAT ORPHENADRINE OSELTAMIVIR OXACILLIN OXALIPLATIN OXAMNIQUINE OXANDROLONE OXAPROZIN OXAZEPAM OXCARBAZEPINE OXICONAZOLE OXTRIPHYLLINE OXYBUTYNIN OXYCODONE OXYMETAZOLINE OXYMETHOLONE OXYMORPHONE OXYTETRACYCLINE OXYTOCIN OZOGAMICIN | Continue >By Generic Name A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z For the latest updates A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z API News! | Brand Names | USActives.com | Vet Products | CMC 2009 FindingHealthOnline ...

... recall: possible Listeria monocytogenes contamination http :// www.fda.gov / oc / po / firmrecalls / scobee12_05.html_UPCOMING PUBLIC MEETINGS Jan. 20-Regulatory Process for Pediatric Mechanical Circulatory Support Devices (Ventricular Assist Devices) Under discussion: regulation and approval of circulatory support devices used for temporary support in pediatric patients http :// www.fda.gov / OHRMS / DOCKETS / 98fr / 05-24271.htm Jan. 23-Joint meeting of the Nonprescription Drugs Advisory Committee and the Endocrinologic and Metabolic Drugs Advisory Committee Under discussion: pending application for over-the-counter use of the prescription weight-loss drug Orlistat Location: Bethesda, Md. http :// www.fda.gov / oc / advisory / accalendar / 2006 / cder12541d012306.html Jan. 24-Joint meeting of the Nonprescription Drugs Advisory Committee and the Pulmonary-Allergy Drugs Advisory Committee Under discussion: the continuing need to designate over-the-counter epinephrine metered-dose inhalers as an essential use of ozone-depleting substances Location: Bethesda, Md. http :// www.fda.gov / oc / advisory / accalendar / 2006 / cder12541d012406.html Feb. 8-9-FDA Anti-Counterfeit Drug Initiative Public Workshop and Vendor Display Under discussion: adoption of radio-frequency identification in the U.S. medicine ...